Dr Maree Knight—Acting Chief Executive Officer, Mater Research

Dr Maree Knight was appointed Acting Chief Executive Officer at Mater Research in May 2018. 

Prior to her appointment as Acting CEO, Maree held the executive position of Deputy Operations, overseeing a portfolio which is responsible for the operational management of Mater Research (including finance, facilities and compliance), continuing to strengthen existing and new partnerships, and research commercialisation activities.

The principal existing partnerships involve the University of Queensland (UQ), as part of the Mater Research–University of Queensland (MRI-UQ), and the Translational Research Institute (TRI). Maree manages the strategic and operational aspects arising from these partnerships.

Maree was trained in Agricultural Science at the University of Adelaide, and later completed her PhD at the University of New England and CSIRO and has most recently completed her MBA degree through the University of Queensland. After completion of her PhD she moved into research support roles within UQ at the School of Biomedical Sciences and later the School of Medicine. Maree joined Mater Research in 2010, principally to co-ordinate the transfer of all biomedical research activity into the newly constructed TRI building at the Princess Alexandra Hospital site and before taking on the position of Deputy Director – Operations, she was the Deputy Director – External Partnerships.